Clinical cancer chemotherapy aimed at potential cell regulators.
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001152:Arsenicals / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy; D002283:Carcinoma, Bronchogenic / Q000188:drug therapy; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D002822:Choriocarcinoma / Q000188:drug therapy; D003110:Colonic Neoplasms / Q000188:drug therapy; D004357:Drug Synergism; D005260:Female; D005459:Fluorides / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy; D008297:Male; D008314:Malonates / Q000627:therapeutic use; D008545:Melanoma / Q000188:drug therapy; D009369:Neoplasms / Q000188:drug therapy*; D010051:Ovarian Neoplasms / Q000188:drug therapy; D010610:Pharyngeal Neoplasms / Q000188:drug therapy; D011247:Pregnancy; D012004:Rectal Neoplasms / Q000188:drug therapy; D012509:Sarcoma / Q000188:drug therapy; D013274:Stomach Neoplasms / Q000188:drug therapy; D013736:Testicular Neoplasms / Q000188:drug therapy; D013964:Thyroid Neoplasms / Q000188:drug therapy; D013997:Time Factors; D014812:Vitamin K / Q000627:therapeutic use
D000970:Antineoplastic Agents; D001152:Arsenicals; D008314:Malonates; D014812:Vitamin K; D006493:Heparin; D005459:Fluorides